Nanosuspensions in drug delivery

Nature Reviews. Drug Discovery
Barrett E Rabinow

Abstract

A surprisingly large proportion of new drug candidates emerging from drug discovery programmes are water insoluble, and therefore poorly bioavailable, leading to abandoned development efforts. These so-called 'brickdust' candidates can now be rescued by formulating them into crystalline nanosuspensions. In the process of overcoming issues involving solubility, additional pharmacokinetic benefits of the drugs so formulated have come to be appreciated. As such, insolubility issues of the past have provoked a paradigm change, which now offers novel solutions for innovative drugs of the future.

References

Jan 1, 1992·The Journal of Pharmacy and Pharmacology·H Viernstein, C Stumpf
Dec 1, 1990·The Journal of Pharmacy and Pharmacology·P JaniA T Florence
Jan 1, 1987·Annals of the New York Academy of Sciences·S S DavisR Kirsh
Jan 1, 1987·European Journal of Drug Metabolism and Pharmacokinetics·P CvelbarM Zorz
Oct 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J G TheisG Koren
Jun 1, 1994·Journal of Clinical Pharmacology·B H BoedekerD H Haynes
Jan 1, 1994·Journal of Ocular Pharmacology·A Joshi
Dec 1, 1996·Pharmaceutical Research·M P DesaiR J Levy
Jun 20, 1997·Science·D A EdwardsR Langer
Jul 1, 1997·Physiological Reviews·S MukherjeeF R Maxfield
Apr 16, 1998·Progress in Retinal and Eye Research·C L BourlaisR Leverge
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·C EvoraR Langer
Mar 4, 1999·International Journal of Pharmaceutics·G J Russell-JonesH Walker
Jul 9, 1999·Cancer Treatment Reviews·S A Grossman, M J Krabak
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·H Toguchi
Dec 28, 1999·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·K D OstranderD M Bondanza
Mar 4, 2000·International Journal of Pharmaceutics·S LiedtkeK Mäder
Mar 17, 2000·Journal of Neuro-oncology·G E ArcherH S Friedman
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·R H MüllerS Gohla
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·J B Dressman, C Reppas
Feb 24, 2001·The Journal of Pharmacy and Pharmacology·K A FosterK L Audus
Mar 17, 2001·Advanced Drug Delivery Reviews·J Kreuter
Jun 26, 2001·Journal of Clinical Pharmacy and Therapeutics·L WillemsK de Beule
Aug 8, 2001·Advanced Drug Delivery Reviews·M A ClarkB H Hirst
Sep 29, 2001·Advanced Drug Delivery Reviews·A T Florence, N Hussain
Mar 9, 2002·Pharmaceutical Research·Claudia Jacobs, Rainer Helmut Müller
Mar 19, 2002·International Journal of Pharmaceutics·Yvette N KonanEric Allémann
Aug 15, 2002·International Journal of Pharmaceutics·Marazban SarkariKeith P Johnston
Aug 30, 2002·Proceedings of the National Academy of Sciences of the United States of America·N TsapisD A Edwards
Oct 31, 2002·Angewandte Chemie·Dieter Horn, Jens Rieger
Dec 20, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lea Ann DaileyThomas Kissel
Feb 21, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Elaine Merisko-LiversidgeEugene R Cooper
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·David Andes

❮ Previous
Next ❯

Citations

Nov 25, 2005·Pharmaceutical Research·Boris Y ShekunovRobert Huff
Dec 28, 2006·Pharmaceutical Research·Boris Y ShekunovAlbert H L Chow
Jan 25, 2007·Pharmaceutical Research·Albert H L ChowBoris Y Shekunov
May 30, 2008·Pharmaceutical Research·Mahesh V Chaubal, Carmen Popescu
May 6, 2009·Pharmaceutical Research·Nashwa El-Gendy, Cory Berkland
Mar 23, 2011·Pharmaceutical Research·Elizabeth Rosado BalmayorRui L Reis
Jun 13, 2012·Pharmaceutical Research·Katharina AnhaltGert Fricker
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Jeffrey D KingsleyChristopher J Destache
Apr 2, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Levente KürtiPiroska Szabó-Révész
Apr 17, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jaime SalazarJan P Möschwitzer
Sep 4, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Annika SarnesLeena Peltonen
Apr 16, 2013·International Journal of Pharmaceutics·Lina DuJunxing Dong
Oct 19, 2013·International Journal of Pharmaceutics·Francesco LaiChiara Sinico
Oct 24, 2013·International Journal of Pharmaceutics·Biswadip SinhaJan P Möschwitzer
May 15, 2013·Journal of the American Chemical Society·Siddharth JambhrunkarChengzhong Yu
Jul 25, 2009·Journal of the American Chemical Society·Eun-Ah YouTeri W Odom
Dec 5, 2009·Journal of the American Chemical Society·Kitae KimAllan S Myerson
Mar 15, 2011·Molecular Pharmaceutics·Shaoling ZhangShinji Sakuma
Feb 3, 2012·ACS Nano·Kathrin FuhrmannJean-Christophe Leroux
Aug 8, 2008·Nature Nanotechnology·Haifei ZhangSteven P Rannard
May 3, 2005·Nature Reviews. Drug Discovery·Howard Rosen, Thierry Abribat
Mar 23, 2007·Chemical Communications : Chem Comm·Randy MellaertsJohan A Martens
Jun 28, 2008·Journal of Biochemistry·Atsushi HiranoKentaro Shiraki
Feb 23, 2013·Current Opinion in Pulmonary Medicine·Shelza BanyalTapan K Mukherjee
Feb 18, 2010·Antimicrobial Agents and Chemotherapy·Gerben van 't KloosterLieven Baert
Jul 3, 2010·Journal of Biomaterials Science. Polymer Edition·Xiaoying WangXinqiao Jia
May 3, 2007·Journal of Biomaterials Science. Polymer Edition·Michael GoldbergXinqiao Jia
Sep 10, 2005·American Journal of Respiratory and Critical Care Medicine·Svetlana GelperinaLeonid Heifets
Jun 28, 2011·AAPS PharmSciTech·Alia A BadawiSami Ahmed Alsammit
Sep 2, 2006·Biological & Pharmaceutical Bulletin·Manju RawatSwarnlata Saraf
Jul 8, 2010·Chemical & Pharmaceutical Bulletin·Yuan GaoJianjun Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Cornelia M Keck, R H Müller
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Elaine Merisko-LiversidgeEugene R Cooper
The Journal of Pharmacy and Pharmacology
V B PatravaleR M Kulkarni
© 2021 Meta ULC. All rights reserved